nhia logo

COVID-19 Resource Center

NHIA has been closely monitoring the COVID-19 situation for the home infusion and specialty pharmacy industry in the U.S. The virus was first detected in China and has made its way around the globe.

COVID-19 is classified as a coronavirus. Coronaviruses are a large family of viruses common in both people and different species of animals. For COVID-19, it appears this outbreak originated from an animal source. The virus spreads easily from person-to-person. For our home infusion and specialty providers, we are in a position to assist in treatment of affected patients in the home and prevent them from seeking care in health care institutions.

We will continue to monitor and update our COVID-19 Resource Center as new information and resources become available, to support our members in providing quality clinical care in the home setting during this time.

 

WEBINARS

April 3, 2020

Legislative Efforts and the Implications of CMS’ Recently Announced Interim Final Rule for Home Infusion Providers
Presenters: Bill Noyes, Shea McCarthy, Connie Sullivan

Stream the webinar here

Download a PDF of the webinar PowerPoint slides here


 

*NEW* Access NHIA’s Talk Infusion Webinar: “COVID-19: What the Home and Specialty Infusion Community Needs to Know”

Time Stamps Dr. Valerianna Amorosa: 3:27
Abby Roth: 34:12
Shea McCarthy: 52:42
Bill Noyes: 1:01
Connie Sullivan: 1:17

Download a PDF of the PowerPoint Slides here

 

 

Coronavirus Resources

NEWS


 

BUSINESS RESOURCES


 

NHIA COVID-19 Guidance


 

GENERAL


 

USP


 

STERILE COMPOUNDING and WORKFLOW


 

NURSING


 

REIMBURSEMENT POLICY

NHIA

CMS

DME MAC and other Medicare Contractors

  • DME MAC: Billing of Part B Drugs to DME MACs During COVID-19 Pandemic - Dispensing Amounts
  • DME MAC POD Signature Guidance
  • CGS Business Continuity: A Message from CGS DME Jurisdiction C Regarding COVID-19
  • Noridian Business Continuity: A Message from Noridian Business Continuity
  • OMHA Appeals
    Although Office of Medicare Hearings and Appeals (OMHA) office space is closed to the general public, OMHA remains open for business with employees working under maximum telework flexibilities per U.S. Office of Personnel Management guidance. OMHA hearings and appeals processing measures are proceeding as scheduled. Unless an appellant is notified directly that a hearing has been postponed or canceled, appellants should continue to appear for hearings by telephone as scheduled. The Chief Administrative Law Judge supports the Administrative Law Judges exercising flexibility with regard to reasonable requests to reschedule hearings. OMHA staff are responding to phone calls to adjudication team phones and toll-free lines. In an effort to continue operations as seamlessly as possible, minimal staff will be on-site in OMHA offices to receive and send mail and faxes. Additional information and updates will be provided as the situation evolves.
  • Performant RAC Audits
    Performant RAC Region 5 is following CMS’ guidance during this Covid-19 emergency. As of March 18, 2020 we will not be sending any new Additional Documentation Request (ADR) letters for 30 days. We are flexible with providers and suppliers with returning medical documentation. If a supplier is having difficulties gathering/submitting documentation, please have them contact our customer service number or email and let us know. We will grant an extension. Automated reviews are not impacted, however a provider/supplier can request a discussion period and if they have difficulties gathering/submitting medical records, please have them contact our customer service number or email and let us know. We will grant an extension. Our customer service number is 866-201-0580 and our email address is: info@performantrac.com
  • CMS- Pending: Sequestration
    The COVID 3 bill suspends Medicare Sequestration May 1, 2020 December 31, 2020

Other


 

CLINICAL and RESEARCH